98-25904. Oral Dosage Form New Animal Drugs; Streptomycin Oral Solution  

  • [Federal Register Volume 63, Number 188 (Tuesday, September 29, 1998)]
    [Rules and Regulations]
    [Pages 51820-51821]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-25904]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Parts 510 and 520
    
    
    Oral Dosage Form New Animal Drugs; Streptomycin Oral Solution
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of an abbreviated new animal drug 
    application (ANADA) filed by Contemporary Products, Inc. The ANADA 
    provides for the use of streptomycin oral solution in drinking water 
    for the treatment of nonspecific infectious enteritis in chickens and 
    for the treatment of bacterial enteritis in swine and calves.
    
    EFFECTIVE DATE: September 29, 1998.
    
    FOR FURTHER INFORMATION CONTACT: Lonnie W. Luther, Center for 
    Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 
    Standish Pl., Rockville, MD 20855, 301-827-0209.
    
    SUPPLEMENTARY INFORMATION: Contemporary Products, Inc., 3788 Elm 
    Springs Rd., P.O. Box 6067, Springdale, AR 72766-6067, filed ANADA 200-
    197 that provides for the use of streptomycin oral solution in drinking 
    water for the treatment of nonspecific infectious enteritis in chickens 
    and for the treatment of bacterial enteritis in swine and calves.
        Contemporary Products, Inc.'s ANADA 200-197 is approved as a 
    generic copy of Veterinary Services, Inc.'s NADA 065-252. ANADA 200-197 
    is approved as of August 3, 1998, and the regulations are amended in 21 
    CFR 520.2158a to reflect the approval. The basis for approval is 
    discussed in the freedom of information summary.
        Contemporary Products, Inc., is not currently listed in the animal 
    drug regulations as the sponsor of an approved application. At this 
    time, 21 CFR 510.600(c)(1) and (c)(2) are amended by adding a new 
    listing for the sponsor.
        In accordance with the freedom of information provisions of 21 CFR 
    part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness 
    data and information submitted to support approval of this application 
    may be seen in the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, 
    between 9 a.m. and 4 p.m., Monday through Friday.
        The agency has determined under 21 CFR 25.33(a)(1) that this action 
    is of a type that does not individually or cumulatively have a 
    significant effect on the human environment. Therefore, neither an 
    environmental assessment nor an environmental impact statement is 
    required.
    
    List of Subjects
    
    21 CFR Part 510
    
        Administrative practice and procedure, Animal drugs, Labeling, 
    Reporting and recordkeeping requirements.
    
    [[Page 51821]]
    
    21 CFR Part 520
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 
    520 are amended as follows:
    
    PART 510--NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 510 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
    
        2. Section 510.600 is amended in the table in paragraph (c)(1) by 
    alphabetically adding a new entry for ``Contemporary Products, Inc.'' 
    and in the table in paragraph (c)(2) by numerically adding a new entry 
    for ``055462'' to read as follows:
    
    Sec. 510.600  Names, addresses, and drug labeler codes of sponsors of 
    approved applications.
    
    * * * * *
        (c) * * *
        (1) * * *
    
    ------------------------------------------------------------------------
                    Firm name and address                  Drug labeler code
    ------------------------------------------------------------------------
      *                    *                    *                    *
                       *                    *                    *
    Contemporary Products, Inc., 3788 Elm Springs Rd.,
     Springdale, AR 72764-6067                                       055462
      *                    *                    *                    *
                       *                    *                    *
    ------------------------------------------------------------------------
    
        (2) * * *
    
    ------------------------------------------------------------------------
     Drug labeler code                  Firm name and address
    ------------------------------------------------------------------------
      *                    *                    *                    *
                       *                    *                    *
    055462............  Contemporary Products, Inc., 3788 Elm Springs Rd.,
                         Springdale, AR 72764-6067
      *                    *                    *                    *
                       *                    *                    *
    ------------------------------------------------------------------------
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        3. The authority citation for 21 CFR part 520 continues to read as 
    follows:
    
        Authority: 21 U.S.C. 360b.
    
    Sec. 520.2158a  [Amended]
    
        4. Section 520.2158a Streptomycin sulfate oral solution is amended 
    in paragraph (b) by removing the phrase ``No. 033008'' and adding in 
    its place `` Nos. 033008 and 055462''.
    
        Dated: August 27, 1998.
    Stephen F. Sundlof,
    Director, Center for Veterinary Medicine.
    [FR Doc. 98-25904 Filed 9-28-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
9/29/1998
Published:
09/29/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-25904
Dates:
September 29, 1998.
Pages:
51820-51821 (2 pages)
PDF File:
98-25904.pdf
CFR: (2)
21 CFR 510.600
21 CFR 520.2158a